Arrakis Therapeutics reduces headcount by 20%
01 Mar 2024 //
ENDPTS
Arrakis Therapeutics to Present at Jefferies Healthcare Conference
01 Jun 2022 //
BUSINESSWIRE
Arrakis Therapeutics to Participate in Upcoming May Investor Conferences
10 May 2022 //
BUSINESSWIRE
Arrakis Therapeutics to Participate in Upcoming Investor Conferences
31 Mar 2022 //
BUSINESSWIRE
Arrakis Tx to Present at Guggenheim Healthcare Talks Oncology Conference
08 Feb 2022 //
BUSINESSWIRE
Amgen partners with Arrakis to develop drugs aimed at RNA
12 Jan 2022 //
BIOPHARMADIVE
Arrakis Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
10 Jan 2022 //
BUSINESSWIRE
Big Pharma can`t get enough from drugging RNA
29 Sep 2021 //
ENDPTS
Roche’s James Sabry zeroes in on a new pathway and he’s paying $135M
19 May 2020 //
ENDPTS